Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

Finally, I take a look at VKTX’s charts to ... resource-intensive drug markets in the United States, which is dominated by juggernauts Novo Nordisk and Eli Lilly. Their semaglutide and ...

WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while grappling with insurance denials and FDA criticism over drug access.

The highest dose ... for NVO’s semaglutide medicines. Analysts expect this move could resolve the FDA drug shortages for Wegovy and Ozempic. If such a decision is reached, compounding pharmacies ...

When it comes to achieving weight loss goals, many people turn to supplements as a way to boost their progress. Two popular ingredients that have gained attention in recent years are the keto diet and ...

Compounded drugs are custom-made and unbranded medications that contain the same active ingredient as a marketed drug, such as semaglutide or tirzepatide, pursuant to a prescription. A shortage of ...

The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of ...

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

and safety checks as drugs approved by the Food and Drug Administration (FDA). Compounded semaglutide and Ozempic should contain the same active ingredient: semaglutide, which is a glucagon-like ...

A US judge has rejected efforts by a compounded drugs industry group to keep making an alternative version of Novo Nordisk’s popular drug semaglutide, opening the door for the US Food and Drug ...

Some pharmacies also produce compounded semaglutide for people who need something different from what’s commercially available — whether that means a custom dose, an alternative form ...